Science and government. A federal agency perspective.
作者信息
Wyngaarden J B
出版信息
Am Psychol. 1984 Sep;39(9):1053-5. doi: 10.1037//0003-066x.39.9.1053.
PMID:6497148
Abstract
摘要
相似文献
1
Science and government. A federal agency perspective.科学与政府。从联邦机构的视角看
Am Psychol. 1984 Sep;39(9):1053-5. doi: 10.1037//0003-066x.39.9.1053.
2
Priority initiatives in health care and research harmed by budget cuts.医疗保健和研究中的优先项目因预算削减而受到损害。
WMJ. 2013 Jun;112(3):141-2.
3
A threat to biomedical research.对生物医学研究的一种威胁。
Science. 1999 Sep 10;285(5434):1671. doi: 10.1126/science.285.5434.1671.
4
AM last page. The federal budget and academic medicine.最后一页。联邦预算与学术医学。
Acad Med. 2012 Jul;87(7):990. doi: 10.1097/ACM.0b013e31825f1e8d.
5
Continuous innovation in health.健康领域的持续创新。
Science. 1997 Jan 3;275(5296):9. doi: 10.1126/science.275.5296.9.
6
Funding: flirting with disaster.资金：与灾难擦肩而过。
Nature. 2013 Jun 27;498(7455):527-8. doi: 10.1038/nj7455-527a.
7
First Lady carries the campaign to NIH.
Lancet. 1994 Mar 5;343(8897):589. doi: 10.1016/s0140-6736(94)91529-6.
8
Donna Shalala: 'leaving footprints' at HHS.唐娜·沙拉拉：在卫生与公众服务部“留下足迹”。
Science. 1996 Mar 1;271(5253):1225-6. doi: 10.1126/science.271.5253.1225.
9
A summary of fraud and abuse issues affecting clinical research programs.
QRC Advis. 1998 Oct;14(12):9-12.
10
The future of research funding in academic medicine.学术医学研究资金的未来。
N Engl J Med. 2009 Apr 9;360(15):1482-3. doi: 10.1056/NEJMp0900132.
Zotero 插件